Win Morgan
Biographic Data
| ID | 9068754 |
|---|---|
| NAME | Win Morgan |
| GIVEN NAMES | Win |
| FAMILY NAME | Morgan |
| SIGNATURE | MORGAN W |
| AFFILIATIONS | Morgan, Lewis & Bockius (United States) |
| ORCID | 0000-0002-7834-3359 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso
BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a go…
No prominent works on this page.
Cost of introducing and delivering malaria vaccine (RTS,S/AS01 E ) in areas of seasonal malaria transmission, Mali and Burkina Faso
BACKGROUND: malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences. This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. METHODS: Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Imm…
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
BACKGROUND: Since 2000, the incidence of measles and rubella has declined as measles-rubella (MR) vaccine coverage increased due to intensified routine immunisation (RI) and supplementary immunisation activities (SIAs). The World Health Assembly commissioned a feasibility assessment of eliminating measles and rubella. The objective of this paper is to present the findings of cost-effectiveness analysis (CEA) of ramping up MR vaccination with a go…
Environmental health (2 works) · Immunology (2 works) · Medicine (2 works) · Vaccination (2 works) · Vaccine Coverage and Hesitancy (2 works) · Business (1 works) · Commodity (1 works) · Congenital rubella syndrome (1 works) · Cost effectiveness (1 works) · Finance (1 works)